MT Genex Corporation (TYO:9820)
Japan · Delayed Price · Currency is JPY 3,795.00
+55.00 (1.47%)
Aug 27, 2026, 3:30 PM JST
MT Genex Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 5,794 | 4,714 | 3,950 | 3,790 | 3,263 | 2,970 | |
Revenue Growth | 42.36% | 19.34% | 4.22% | 16.15% | 9.87% | -1.30% |
Cost of Revenue | 4,498 | 3,617 | 2,944 | 2,829 | 2,414 | 2,165 |
Gross Profit | 1,296 | 1,097 | 1,006 | 961 | 849 | 805 |
Selling, General & Admin | 572 | 568 | 515 | 476 | 442 | 434 |
Amortization of Goodwill & Intangibles | 47 | 47 | 65 | 34 | 34 | 34 |
Operating Expenses | 637 | 633 | 595 | 523 | 484 | 476 |
Operating Income | 659 | 464 | 411 | 438 | 365 | 329 |
Interest Expense | - | - | - | - | - | -1 |
Interest & Investment Income | 25 | 23 | 15 | 10 | 10 | 11 |
Other Non Operating Income (Expenses) | -1 | 2 | 1 | 1 | 1 | 2 |
EBT Excluding Unusual Items | 683 | 489 | 427 | 449 | 376 | 341 |
Gain (Loss) on Sale of Investments | - | - | 3 | 2 | 5 | - |
Gain (Loss) on Sale of Assets | 1 | 1 | - | - | - | - |
Pretax Income | 684 | 490 | 430 | 451 | 381 | 341 |
Income Tax Expense | 248 | 176 | 166 | 174 | 140 | 129 |
Net Income | 436 | 314 | 264 | 277 | 241 | 212 |
Net Income to Common | 436 | 314 | 264 | 277 | 241 | 212 |
Net Income Growth | 60.89% | 18.94% | -4.69% | 14.94% | 13.68% | -6.61% |
Shares Outstanding (Basic) | 1 | 1 | 1 | 1 | 1 | 1 |
Shares Outstanding (Diluted) | 1 | 1 | 1 | 1 | 1 | 1 |
Shares Change | - | - | - | - | - | - |
EPS (Basic) | 405.21 | 291.82 | 245.35 | 257.43 | 223.98 | 197.03 |
EPS (Diluted) | 405.21 | 291.82 | 245.35 | 257.43 | 223.98 | 197.03 |
EPS Growth | 60.88% | 18.94% | -4.69% | 14.94% | 13.68% | -6.61% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | 54 | 277 | 257 | 77 | 389 |
Free Cash Flow Per Share | - | 50.19 | 257.44 | 238.85 | 71.56 | 361.52 |
Dividend Per Share | 40.000 | 40.000 | 40.000 | 40.000 | 40.000 | 40.000 |
Dividend Growth | 0% | 0% | 0% | 0% | 0% | 0% |
Gross Margin | 22.37% | 23.27% | 25.47% | 25.36% | 26.02% | 27.10% |
Operating Margin | 11.37% | 9.84% | 10.41% | 11.56% | 11.19% | 11.08% |
Profit Margin | 7.52% | 6.66% | 6.68% | 7.31% | 7.39% | 7.14% |
Free Cash Flow Margin | - | 1.15% | 7.01% | 6.78% | 2.36% | 13.10% |
EBITDA | 725.25 | 534 | 496 | 487 | 408 | 373 |
EBITDA Margin | 12.52% | 11.33% | 12.56% | 12.85% | 12.50% | 12.56% |
D&A For EBITDA | 66.25 | 70 | 85 | 49 | 43 | 44 |
EBIT | 659 | 464 | 411 | 438 | 365 | 329 |
EBIT Margin | 11.37% | 9.84% | 10.41% | 11.56% | 11.19% | 11.08% |
Effective Tax Rate | 36.26% | 35.92% | 38.61% | 38.58% | 36.74% | 37.83% |